HOME >> BIOLOGY >> NEWS
Immune cell receptors act in combination to regulate attack

The complexities of the mammalian immune system allow our bodies to fend off countless diseases. But researchers are still working to pin down exactly how it works -- and to understand why some people's antibodies, and some therapeutic antibodies, are better able to fight off disease than others'. In research published in today's issue of Science, Rockefeller researchers show how a newly discovered receptor may be partly responsible.

Two competing theories exist as to why some subclasses of antibodies, called IgG isotypes, are more effective against pathogens than others. The older and most-accepted model holds that certain isotypes are better at activating blood proteins called complement, which bind to a viral, bacterial or tumor cell and kill it by punching holes in its surface. An alternative model, however, suggests that the different isotypes have varying affinities to the four different antibody receptors on an immune cell's surface -- three of these receptors act as activators, one acts as an inhibitor, and together they determine whether the cell is turned on or off.

A new study by Jeffrey Ravetch, head of Rockefeller's Leonard Wagner Laboratory of Molecular Genetics and Immunology, and Falk Nimmerjahn, a postdoctoral fellow in the lab and the paper's first author, provides overwhelming evidence in favor of the second theory. Their research shows that it's the receptors that dictate how efficiently an antibody will recognize a foreign cell, bind to it, and destroy it. By studying mice in which one receptor at a time was blocked, and then comparing their ability to fight off tumors, Ravetch and Nimmerjahn illustrate how a receptor they'd discovered earlier this year is a vital piece of the puzzle. It seems that different antibody isotypes bind to different receptors, thus determining how effectively a foreign cell will be destroyed: If the antibody selectively engages only the inhibitory receptor, the immune cell won't attack. The new recepto
'"/>

Contact: Kristine Kelly
kkelly@rockefeller.edu
212-327-7146
Rockefeller University
2-Dec-2005


Page: 1 2

Related biology news :

1. Immune system escape hatch gives cancer cells traction
2. Immune antibodies penetrate neurons to clear Alzheimers-linked amyloid
3. Immune response to cancer stem cells may dictate cancers course
4. Immune systems in breast cancer survivors who suffer from fatigue fail to shut off after therapy
5. Immune response to HIV in the brain
6. Immune substances may help antibody-based drugs fight cancer
7. Immune system has evolved to prevent autoimmune disease
8. Immune cells known as macrophages linked to growth of lymph vessels in eyes, scientists discover
9. Immune systems distress signal tells bacteria when to strike back
10. Immune cells genetic jam session is controlled by cell division machinery
11. Immune systems initial response to cancer under study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... ... complex problems for life sciences companies and government agencies, announced the recent ... management consulting expertise to Tunnell, with significant experience assessing, designing, and managing ...
(Date:2/6/2020)... ... February 06, 2020 , ... Syntactx, ... device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the ... oversees the development and execution of regulatory plans designed to help clients ...
(Date:2/1/2020)... (PRWEB) , ... February 01, 2020 , ... Liver cancer, ... world and about 700,000 die from the disease. HCC is the 5th most common ... place among all countries when it comes to incidence of HCC, while China has ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... 2020 , ... Valencell, the leading innovator in wearable biometric ... Halma plc , a FTSE 100 global group of life-saving technology companies, ... Joshua Fund. A representative from Halma will join the Valencell board of directors. ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader in ... controllers ideal for BioPharm OEMS. Sierra also announces RedyCompact™ flow ... instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable no-drift ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC ... Region Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s ... brings over 30 years of sales experience working across multiple different market sectors ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... the vendor qualification process, a critical element of clinical trial set up and ... the vendor qualification process creates delays in initiation in 7% of clinical trials ...
Breaking Biology Technology:
Cached News: